28 results
IBS-C Pharmacotherapy

Polyethylene glycol
Lubiprostone
Linaclotide
Plecanatide
Tegaserod
Tenapanor

#IBSC #IBS #Constipation #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
#Constipation #Irritable ... #Bowel #Syndrome ... #pharmacology # ... table #comparison #management
IBS-D Pharmacotherapy

Loperamide
Rifaximin
Eluxadoline
Alosetron
Antispasmodics
Tricyclic antidepressants
SSRIs

#IBSD #IBS #Diarrhea #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
IBS #Diarrhea #Irritable ... #Bowel #Syndrome ... #pharmacology # ... table #comparison #management
Irritable Bowel Syndrome (IBS) Treatment Options
Amitiza (Lubiprostone)
Antidepressants: Celexa, Wellbutrin, Prozac, Paxil, Nortriptyline, and Zoloft
Bentyl (Dicyclomine)
Creon
Ducolax
Imodium, Maalox,
Irritable Bowel ... Syndrome (IBS) Treatment ... #bowel #syndrome ... #constipation #management ... #pharmacology #
Irritable Bowel Syndrome (IBS) - Pathophysiology, Diagnosis and Management Algorithm
Risk factors: Previous acute enteric infection, Female
Irritable Bowel ... Diagnosis and Management ... (e.g. fibromyalgia ... Pregabalin #IBS #Irritable ... Pathophysiology #Diagnosis #Management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... dose of 20–60 mg/kg ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Muscarinic Receptor Agonists and Antagonists 
Muscarinic Receptor Agonists
Methacholine
 • Diagnosis of bronchial airway
Carbachol
 • Glaucorna (topical
due to Sjögren syndrome ... symptomatic bradycardia (e.g ... Diarrhea-predominant irritable ... bowel syndrome ... #Medications #Pharmacology
IBS-C Pharmacologic Therapies and Recommendations
Linaclotide, Plecanatide, Lubiprostone, PEG laxatives, Tegaserod, Rifaximin, Eluxadoline, Alosetron, Loperamide, TCAs, SSRIs,
IBS-C Pharmacologic ... Antispasmodics #IBSC #irritable ... #bowel #syndrome ... #medications #management ... Recommendations #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
amphotericin B, 3 to 5 mg/kg ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Benznidazole 5–8 mg/kg ... Nifurtimox 8–10 mg/kg ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Cytokine Activation Syndrome ... Tocilizumab 4-8mg/kg ... Siltuximab 11mg/kg ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications